B
NUVB icon

Braidwell’s Nuvation Bio NUVB Stock Holding History

Braidwell’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,122,900
Closed -$7.42M – 92
2023
Q2 		$7.42M Hold
4,122,900
– – 0.24% 76
2023
Q1 		$6.84M Hold
4,122,900
– – 0.23% 71
2022
Q4 		$7.92M Buy
+4,122,900
New +$8.34M 0.27% 78

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Braidwell's NUVB Position: Q3 2023 in Review

Braidwell sold out of Nuvation Bio (NUVB) in Q3 2023, closing a stake of 4,122,900 shares — an estimated $7.42M sold.

Braidwell first reported a position in NUVB in Q4 2022 and held it in 3 quarters. The position peaked at $7.92M in Q4 2022. 125 funds tracked by Wall St. Rank hold NUVB as of Q3 2023.

  • Braidwell reported no remaining Nuvation Bio position as of Q3 2023 after selling out during the quarter.
  • Braidwell sold 4,122,900 Nuvation Bio shares in Q3 2023, an estimated $7.42M.
  • Braidwell first reported a position in Nuvation Bio in Q4 2022 and held it in 3 quarters.
  • Braidwell's Nuvation Bio position peaked at $7.92M in Q4 2022.
  • 125 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2023.

Based on Braidwell's 13F filing for Q3 2023, filed 14 Nov 2023.